在阿尔茨海默氏病的人类大脑中长非编码RNA的空间表达
bioRxiv : the preprint server for biology
|November 18, 2024
概括
长非编码RNAs (lncRNAs) 在老年大脑中显示出明显的空间模式,特定的lncRNAs与阿尔茨海默病 (AD) 病理学和表观遗传调节有关,为AD机制提供了新的见解.
科学领域:
- 神经科学是一个神经科学.
- 基因组学就是基因组学.
- 分子生物学分子生物学
背景情况:
- 长非编码RNAs (lncRNAs) 是生物过程中的关键调节者.
- lncRNAs的失调越来越多地与衰老和阿尔茨海默病 (AD) 有关.
研究的目的:
- 在老年人背侧前额皮质中绘制 lncRNAs 的空间表达.
- 为了确定参与阿尔茨海默病 (AD) 发病的lncRNAs.
主要方法:
- 从21个个人的78个死后脑部部分 (ROSMAP队列) 的空间转录分析.
- 网络分析以确定AD中的基因模块和差异表达 (DE) lncRNAs.
- 基因组丰富分析和统计建模以探索功能角色.
主要成果:
- 在老年大脑中,lncRNAs显示出比mRNA更大的分区域特异性表达.
- 确定了193个基因模块,包括参与关键生物过程的lncRNA丰富模块.
- AD DE lncRNAs比AD DEmRNAs显示出更高的亚区域特异性,并且与表观遗传调节有关,包括HDAC目标,如OIP5-AS1.1.
结论:
- 这项研究为老年人大脑提供了一个空间 lncRNA 表达资源.
- lncRNA OIP5-AS1与HDAC蛋白 (例如,HDAC11) 的相互作用与TAU纠和斑块负担等AD特征有关.
- 在阿尔茨海默氏病的发病过程中,lncRNAs代表了潜在的功能参与者和治疗点.
更多相关视频
04:22Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
Published on: May 20, 2024
769
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
14.8K
相关概念视频
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Alzheimer's Disease: Overview
448
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
448
